Effect of a somatostatin analogue (SMS 201–995) on renal function and urinary protein excretion in diabetic rats
- 15 April 1991
- journal article
- Published by Elsevier in Journal of Diabetic Complications
- Vol. 5 (2-3) , 181-183
- https://doi.org/10.1016/0891-6632(91)90066-x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized ratsDiabetologia, 1989
- Experimental atherosclerosis-like lesions induced by hyperinsulinism in Wistar ratsDiabetes, 1989
- The effect of a somatostatin analogue (SMS 201-995, sandostatin) on the concentration of phosphoribosyl pyrophosphate and the activity of the pentose phosphate pathway in the early renal hypertrophy of experimental diabetes in the ratBiochemical Medicine and Metabolic Biology, 1988
- Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathyScandinavian Journal of Clinical and Laboratory Investigation, 1986
- Reduction in portal vein blood flow by somatostatinDiabetes, 1979